Studying a sugar protein to understand type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study is looking at how a sugar-processing protein, called GLUT1, affects the immune system in people with type 1 diabetes. It uses blood samples already stored in a biobank, so no new samples or treatments are needed from you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult aged 18 or older.
- You have a confirmed diagnosis of type 1 diabetes.
- You have a stored blood sample (specifically white blood cells) at the San Raffaele hospital biobank.
- You previously gave permission for your blood sample to be used in research.
- You do not have other serious illnesses that could affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at children who have just started insulin for new-onset type 1 diabetes. It aims to test an intervention early in the course of the disease, which may help change how the immune system and diabetes progress.
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
This study looks at immune cells in children who were recently diagnosed with type 1 diabetes. It involves one extra blood draw to better understand how the immune system attacks the pancreas. If you join, no new treatments are given—just observation and analysis of your child's immune cells.
This study looks at how your immune system changes over time and how that relates to developing type 1 diabetes. You may be able to join if you can have blood drawn, since the study focuses on blood samples.
This study collects skin or blood samples to create stem cells that can be turned into insulin-producing pancreatic cells. It may help people with diabetes and other beta cell disorders by providing cells for future research or treatments.
This study looks at genetic patterns in families where someone has type 1 diabetes (an autoimmune condition). It may help researchers understand why type 1 diabetes happens and who is at risk.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.